PROCEPT BioRobotics Corp (PRCT) stock
PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3050% below fair value
$23.80+0.29 (+1.23%)
Close on Nov 13, 2026Market cap $1.36BP/E –Yield –
PROCEPT BioRobotics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
PROCEPT BioRobotics's price to sales ratio was 4.0× on Nov 11, 2026, against 5.9× a year earlier. Over the last 5 years it ranged from 3.1× to 45.1×, with a median of 18.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.0× | −1.9 |
| 2025 | Dec 31, 2025 | 5.9× | −15.1 |
| 2024 | Dec 31, 2024 | 21.0× | +2.8 |
| 2023 | Dec 29, 2023 | 18.2× | −12.1 |
| 2022 | Dec 30, 2022 | 30.3× | −9.2 |
| 2021 | Dec 31, 2021 | 39.5× | – |
See a number that looks wrong?